These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 10769641

  • 1. Involvement of p21Waf1 in mediating inhibition of paclitaxel-induced apoptosis by epidermal growth factor in MDA-MB-468 human breast cancer cells.
    Fang M, Liu B, Schmidt M, Lu Y, Mendelsohn J, Fan Z.
    Anticancer Res; 2000; 20(1A):103-11. PubMed ID: 10769641
    [Abstract] [Full Text] [Related]

  • 2. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [Abstract] [Full Text] [Related]

  • 3. Differential modulation of paclitaxel-mediated apoptosis by p21Waf1 and p27Kip1.
    Schmidt M, Lu Y, Liu B, Fang M, Mendelsohn J, Fan Z.
    Oncogene; 2000 May 11; 19(20):2423-9. PubMed ID: 10828884
    [Abstract] [Full Text] [Related]

  • 4. Involvement of p21 in mitotic exit after paclitaxel treatment in MCF-7 breast adenocarcinoma cell line.
    Barboule N, Chadebech P, Baldin V, Vidal S, Valette A.
    Oncogene; 1997 Dec 04; 15(23):2867-75. PubMed ID: 9419978
    [Abstract] [Full Text] [Related]

  • 5. Taxol-induced p34cdc2 kinase activation and apoptosis inhibited by 12-O-tetradecanoylphorbol-13-acetate in human breast MCF-7 carcinoma cells.
    Shen SC, Huang TS, Jee SH, Kuo ML.
    Cell Growth Differ; 1998 Jan 04; 9(1):23-9. PubMed ID: 9438385
    [Abstract] [Full Text] [Related]

  • 6. MDA468 growth inhibition by EGF is associated with the induction of the cyclin-dependent kinase inhibitor p21WAF1.
    Xie W, Su K, Wang D, Paterson AJ, Kudlow JE.
    Anticancer Res; 1997 Jan 04; 17(4A):2627-33. PubMed ID: 9252692
    [Abstract] [Full Text] [Related]

  • 7. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1.
    Hu M, Wang J, Chen P, Reilly RM.
    Bioconjug Chem; 2006 Jan 04; 17(5):1280-7. PubMed ID: 16984139
    [Abstract] [Full Text] [Related]

  • 8. Reduced expression of p53 and p21WAF1/CIP1 sensitizes human breast cancer cells to paclitaxel and its combination with 5-fluorouracil.
    Johnson KR, Fan W.
    Anticancer Res; 2002 Jan 04; 22(6A):3197-204. PubMed ID: 12530065
    [Abstract] [Full Text] [Related]

  • 9. Cytotoxic activity of epidermal growth factor-genistein against breast cancer cells.
    Uckun FM, Narla RK, Jun X, Zeren T, Venkatachalam T, Waddick KG, Rostostev A, Myers DE.
    Clin Cancer Res; 1998 Apr 04; 4(4):901-12. PubMed ID: 9563884
    [Abstract] [Full Text] [Related]

  • 10. The role of p21 in interferon gamma-mediated growth inhibition of human breast cancer cells.
    Gooch JL, Herrera RE, Yee D.
    Cell Growth Differ; 2000 Jun 04; 11(6):335-42. PubMed ID: 10910100
    [Abstract] [Full Text] [Related]

  • 11. Taxol-induced growth arrest and apoptosis is associated with the upregulation of the Cdk inhibitor, p21WAF1/CIP1, in human breast cancer cells.
    Choi YH, Yoo YH.
    Oncol Rep; 2012 Dec 04; 28(6):2163-9. PubMed ID: 23023313
    [Abstract] [Full Text] [Related]

  • 12. Contribution of reactive oxygen species and caspase-3 to apoptosis and attenuated ICAM-1 expression by paclitaxel-treated MDA-MB-435 breast carcinoma cells.
    Fawcett H, Mader JS, Robichaud M, Giacomantonio C, Hoskin DW.
    Int J Oncol; 2005 Dec 04; 27(6):1717-26. PubMed ID: 16273228
    [Abstract] [Full Text] [Related]

  • 13. The role of tyrosine kinase Etk/Bmx in EGF-induced apoptosis of MDA-MB-468 breast cancer cells.
    Chen KY, Huang LM, Kung HJ, Ann DK, Shih HM.
    Oncogene; 2004 Mar 11; 23(10):1854-62. PubMed ID: 14676838
    [Abstract] [Full Text] [Related]

  • 14. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
    Yin F, Giuliano AE, Law RE, Van Herle AJ.
    Anticancer Res; 2001 Mar 11; 21(1A):413-20. PubMed ID: 11299771
    [Abstract] [Full Text] [Related]

  • 15. 3,3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells.
    McGuire KP, Ngoubilly N, Neavyn M, Lanza-Jacoby S.
    J Surg Res; 2006 May 15; 132(2):208-13. PubMed ID: 16580691
    [Abstract] [Full Text] [Related]

  • 16. Enhanced sensitization to taxol-induced apoptosis by herceptin pretreatment in ErbB2-overexpressing breast cancer cells.
    Lee S, Yang W, Lan KH, Sellappan S, Klos K, Hortobagyi G, Hung MC, Yu D.
    Cancer Res; 2002 Oct 15; 62(20):5703-10. PubMed ID: 12384528
    [Abstract] [Full Text] [Related]

  • 17. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways.
    Tuck AB, Hota C, Wilson SM, Chambers AF.
    Oncogene; 2003 Feb 27; 22(8):1198-205. PubMed ID: 12606946
    [Abstract] [Full Text] [Related]

  • 18. Complex regulation of the fibroblast growth factor-binding protein in MDA- MB-468 breast cancer cells by CCAAT/enhancer-binding protein beta.
    Kagan BL, Henke RT, Cabal-Manzano R, Stoica GE, Nguyen Q, Wellstein A, Riegel AT.
    Cancer Res; 2003 Apr 01; 63(7):1696-705. PubMed ID: 12670924
    [Abstract] [Full Text] [Related]

  • 19. Bone morphogenetic protein-2 blocks MDA MB 231 human breast cancer cell proliferation by inhibiting cyclin-dependent kinase-mediated retinoblastoma protein phosphorylation.
    Ghosh-Choudhury N, Woodruff K, Qi W, Celeste A, Abboud SL, Ghosh Choudhury G.
    Biochem Biophys Res Commun; 2000 Jun 16; 272(3):705-11. PubMed ID: 10860819
    [Abstract] [Full Text] [Related]

  • 20. Paclitaxel induces apoptosis via protein kinase A- and p38 mitogen-activated protein-dependent inhibition of the Na+/H+ exchanger (NHE) NHE isoform 1 in human breast cancer cells.
    Reshkin SJ, Bellizzi A, Cardone RA, Tommasino M, Casavola V, Paradiso A.
    Clin Cancer Res; 2003 Jun 16; 9(6):2366-73. PubMed ID: 12796407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.